General Internal Medicine

Addiction Medicine

Questions discussed in this category

Is there a role for use of GLP-1/GIP receptor agonists in the management of substance use disorders, whether or not they meet other inclusion criteria for their use?

2 Answers available

How do you approach weaning patients off of buprenorphine?

7 Answers available

What are your preferred non-benzodiazepine therapies for the hyperactive/agitated phase of methamphetamine withdrawal, both in the hospital and in the office?

Assume QTc is not prolonged, electrolytes are reasonably normal, and the patient is not already on heavy psychotropic polypharmacy.

1 Answer available

Papers discussed in this category

Journal of addiction medicine, 2021 May-Jun 01

Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case Series.

The American journal on addictions, 2023 Mar 20

Case series: Voluntary discontinuation of sublingual buprenorphine treatment for opioid use disorder using extended-release buprenorphine.

Drug and alcohol dependence, 2024 Sep 07

Potential role of glucagon-like peptide-1 (GLP-1) receptor agonists in substance use disorder: A systematic review of randomized trials.

JAMA psychiatry, 2025 Apr 01

Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial.

Related Topics in General Internal Medicine